Contracts are essential to the maintenance of high quality care in healthcare institutions. As well, they are necessary to protect the interests of nurses who provide this care
Which of the following issues is most likely to be addressed in a contract for nurses?
A) The process that should be followed when distributing overtime work
B) The obligation of nurses to participate in nursing research
C) The details of the organizational structure of a hospital
D) The relationships among nurses, physicians and members of other health disciplines
Ans: A
Contracts commonly address such issues as overtime work. Relationships between
care providers, participation in research, and organizational structure of a hospital are issues
that are normally outside the purview of a nursing contract.
You might also like to view...
Which finding in a female client by the nurse would receive the highest priority of further diagnostics?
a. Tender moveable masses throughout the breast tissue b. A 3-cm firm, defined mobile mass in the lower quadrant of the breast c. Nontender immobile mass in the upper outer quadrant of the breast d. Small, painful mass under warm reddened skin
A nurse is admitting a patient for outpatient eye surgery. The nurse routinely administers preoperative medications for eye surgery and is aware that an increased dosage of a mydriatic is likely when given to a member of what ethnic group?
A) African Americans B) German Americans C) Irish Americans D) Scandinavian Americans
In the solution D5NS, dextrose is the solute and normal saline is the solvent
Indicate whether the statement is true or false
The Pure Food and Drug Act (PFDA) of 1906 was significant in that it gave the government the power to prohibit drug labels from claiming false therapeutic benefits
However, there were still several weaknesses in the legislature of this act. Which statements most accurately describe these weaknesses? 1. This law did not require drug manufacturers to prove that the drug was effective in its claims. 2. This law did not prevent drugs from being marketed for any disease. 3. This law required all drug labels to accurately describe their contents. 4. This law required adequate testing for safety prior to marketing. 5. This law did not encourage the development of drugs for rare or unusual disorders.